For PDGFRB, which is in the EMT pathway with increased expression in the transition from healthy to low serosa, we found a moderate correlation between its expression and cancer-associated fibroblast in borderline tissue (r = 0.56, p = 0.0016) and a high correlation in low serous (r = 0.75, p = 6.6 × 10−7). Here, PDGFRB is linked to cancer.